Baker Daniel G. — SEC Form 4 filings
SEC reporting owner CIK 2046802. 10 Form 4 filings on record with FilingPulse; latest filed 2026-09-14.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-11-29 to 2026-09-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | Director | 4 | — | — | 4 |
| Cue Biopharma, Inc. (CUE) | CHIEF DEVELOPMENT OFFICER | 4 | — | — | 4 |
| Shattuck Labs, Inc. (STTK) | Director | 2 | — | — | 2 |
Form 4 filings — Baker Daniel G.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-14 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Shattuck Labs, Inc. (STTK) | Grant/award (A): 81,000 (derivative) @ $0 | EDGAR |
| 2026-04-10 | 4 | Cue Biopharma, Inc. (CUE) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | Cue Biopharma, Inc. (CUE) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-09-02 | 4 | Shattuck Labs, Inc. (STTK) | Grant/award (A): 66,300 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2025-03-25 | 4 | Cue Biopharma, Inc. (CUE) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 27,500 (derivative) @ $0 | EDGAR |
| 2024-11-29 | 4 | Cue Biopharma, Inc. (CUE) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2046802 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →